Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced ...
Exact Sciences Corp. announced pivotal results from the ALTUS study, showing its Oncoguard Liver blood test outperformed the standard ultrasound in early-stage liver cancer detection and overall ...
Cancer diagnostics firm Helio Genomics says its five-year clinical trial shows its AI-based diagnostic test is two to four times more effective than typical ultrasounds. Helio’s pivotal trial, which ...
MedPage Today on MSN
Blood Test May Be a 'Viable Alternative' in Liver Cancer Surveillance
An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting ...
Figure 2: Architectural frameworks for uncertainty quantification in hepatobiliary image processing. (A) T1ρ mapping framework with integrated uncertainty estimation. The probabilistic neural network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback